Bupa confirms the appointment of James Lenton as Group CFO and as an executive director
Further to the announcement made on 28 April 2021, James Lenton has today been appointed to Bupa’s Board as an executive director following receipt of his regulatory approval to be Bupa’s new Group Chief Financial Officer. Martin Potkins, Interim CFO, has therefore today stepped down from the Board.
In his previous role, James was CFO of Hammerson plc, a FTSE 250 owner and manager of properties with a European portfolio. Prior to Hammerson, James was both CFO, and a board member, of AIG’s European Group, a position he held for four years, delivering new profitability and financing strategies. Earlier in his career he was a Partner at EY providing a range of assurance and advisory services including M&A, financing and external audit. His clients included FTSE 100 companies and financial services groups.
Notes to editor
Enquiries
Investors: Gareth Evans (Treasury): [email protected]
About Bupa
Bupa's purpose is helping people live longer, healthier, happier lives and making a better world.
We are an international healthcare company serving over 31 million customers worldwide. With no shareholders, we reinvest profits into providing more and better healthcare for the benefit of current and future customers.
We directly employ around 85,000 people, principally in the UK, Australia, Spain, Chile, Poland, New Zealand, Hong Kong SAR, Turkey, Brazil, Mexico, the US, Middle East and Ireland. We also have associate businesses in Saudi Arabia and India.
